San Francisco, USA-based inflammatory disease biotech Third Harmonic Bio (Nasdaq: THRD) saw its shares rocket almost 40% to $5.09 as the company revealed an orderly exit plan.

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Biotechnology will have a transformative impact on defense, supply chains, agriculture, health and computing, all areas that ...